SARS-CoV-2 Nucleoprotein (126-140)


  • Description

  • Application Data


NKDGIIWVATEGALN is a SARS-CoV-2 nucleoprotein (126-140) epitope. It is an epitope suitable for anti-viral targeting.

See full description

Application Data

Catalogue number crb1001762
Molecular Weight 1599.8
Sequence (one letter code)


Sequence (three letter code)


Purity >95%
Storage -20°C

Gupta et al., (2006). SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens. Virology347(1): 127.

Zhuang et al., (2021). Mapping and role of T cell response in SARS-CoV-2–infected mice. JEM218(4). DOI: 10.1084/jem.20202187.

Manufactured in: United Kingdom
Data Sheet Data Sheet Material Safety Data Sheet (MSDS)

The coronavirus (CoV) nucleoprotein is the major component of CoV structural proteins. Also known as the nucleocapsid protein, it is an abundant RNA-binding protein critical for viral genome packaging. These factors make nucleoprotein a good target for developing new antiviral drugs. In addition, the identification of epitopes within the nucleoprotein sequence can help design more effective SARS-CoV-2 vaccines.

Models have predicted epitopes exhibiting antigenicity, stability and interactions with MHC class-I and class-II molecules. Nucleoprotein (56-70) is an epitope candidate with various HLA restrictions. This epitope can be used to better vaccine design for more durable CD4+ and CD8+ T cell responses for long-lasting immunity.

We have a large collection of SARS-CoV-2 for you to choose from to complement your research. Explore our antiviral peptides and epitope families here for the full list.

SARS-CoV-2 Nucleoprotein (126-140)

Cat No.Pack SizePriceQty.
Bulk Quote

You may also like…

  • SARS-CoV-2 Nucleoprotein (271-285)


    View products
  • SARS-CoV-2 Nucleoprotein (266-280)


    View products
  • SARS-CoV-2 Nucleoprotein (1-17)


    View products
  • SARS-CoV-2 Nucleoprotein (104-121)


    View products